TP53 and MDM2 Gene Polymorphisms and Risk of Hepatocellular Carcinoma in Italian Patients

Infectious Agents and Cancer - United Kingdom
doi 10.1186/1750-9378-6-13
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

VDR Gene Polymorphisms and Risk of Hepatocellular Carcinoma

Sohag Medical Journal
2019English

TP53 and MDM2 Polymorphisms and the Risk of Endometrial Cancer in Postmenopausal Women

Medical Oncology
MedicineCancer ResearchOncologyHematology
2014English

The Association of TNF-308 (G/A) Gene Polymorphisms and Hepatocellular Carcinoma Risk: A Meta-Analysis

Chinese Journal of Cancer Research
Cancer ResearchOncology
2016English

249ser TP53 Mutation in Plasma DNA, Hepatitis B Viral Infection, and Risk of Hepatocellular Carcinoma

Oncogene
Cancer ResearchGeneticsMolecular Biology
2005English

The Association of miR34b/c and TP53 Gene Polymorphisms With Wilms Tumor Risk in Chinese Children

Bioscience Reports
BiochemistryCell BiologyMolecular BiologyBiophysics
2020English

Accelerated Decline in Lung Function in Cigarette Smokers Is Associated With TP53/MDM2 Polymorphisms

Human Genetics
Genetics
2009English

Association Between miR-199a Rs74723057 and MET Rs1621 Polymorphisms and the Risk of Hepatocellular Carcinoma

Oncotarget
Oncology
2016English

The Association Between Two Common Polymorphisms in MicroRNAs and Hepatocellular Carcinoma Risk in Asian Population

PLoS ONE
Multidisciplinary
2013English

Association Between the Rs9131 and Rs3806792 Polymorphisms of the CXCL2 Gene and the Risk of HBV-related Hepatocellular Carcinoma in a Guangxi Population

Journal of Clinical Laboratory Analysis
AllergyImmunologyBiochemistryPublic HealthMedical Laboratory TechnologyClinical BiochemistryHematologyMicrobiologyEnvironmentalOccupational Health
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy